Literature DB >> 16522535

Autoimmune progesterone dermatitis.

Barbara Cocuroccia1, Paolo Gisondi, Emanuela Gubinelli, Giampiero Girolomoni.   

Abstract

Autoimmune progesterone dermatitis (APD) is a rare disorder characterized by recurrent polymorphous skin manifestations, which appear or are exacerbated during the luteal phase of the menstrual cycle. The hallmarks for diagnosis include premenstrual flare, its prevention with the inhibition of ovulation, and positive skin reaction to intradermal injection of progesterone. The mainstay of treatment is to inhibit the secretion of endogenous progesterone by suppressing ovulation. Bilateral oophorectomy may be necessary in patients with severe and refractory symptoms. We report herein the case of a 38-year-old woman who developed recurrent and cyclic vesiculobullous eruptions clinically suggestive of erythema multiforme or autoimmune bullous diseases. The skin manifestations turned out to be APD. The patient was treated with tamoxifen 20 mg daily with complete symptom remission after 4 months.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16522535     DOI: 10.1080/09513590500216735

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  4 in total

Review 1.  Progestogen Hypersensitivity.

Authors:  Rung-Chi Li; Kathleen M Buchheit; Jonathan A Bernstein
Journal:  Curr Allergy Asthma Rep       Date:  2018-01-19       Impact factor: 4.806

Review 2.  Progestogen Sensitization: a Unique Female Presentation of Anaphylaxis.

Authors:  Jonathan A Bernstein
Journal:  Curr Allergy Asthma Rep       Date:  2020-01-28       Impact factor: 4.806

3.  Ulcerative Stomatitis as the Sole Manifestation of Progesterone Hypersensitivity.

Authors:  Suhail H Al-Amad
Journal:  Oman Med J       Date:  2020-11-29

Review 4.  Catamenial dermatoses associated with autoimmune, inflammatory, and systemic diseases: A systematic review,.

Authors:  Cameron Zachary; Nathan Fackler; Margit Juhasz; Christine Pham; Natasha Atanaskova Mesinkovska
Journal:  Int J Womens Dermatol       Date:  2019-10-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.